CHARLESTON, S.C., Nov. 23, 2010 (GLOBE NEWSWIRE) -- Revolutions Medical ("Revolutions Medical" or the "Company") (OTCBB:RMCP) met with interested global distributors and showed, for the first time, the new market samples of its 3ml RevVac Safety syringe. The company has already received signed pre-production commitment letters from some of these distributors for over 12 million syringes to be delivered next year and will continue to pursue full distribution agreements with additional sales volumes over the coming months. The Company's initial shipment date is still on schedule for March/April 2011.
"The whole Revolutions Medical team was very pleased with both receptions in Dusseldorf, Germany and in London, England. We always felt that we had a special product which is uniquely poised in the safety syringe market and now this has been confirmed with the overall excitement and volume commitments by distributors. We do expect to receive additional signed commitment letters soon as we ramp up production with our Chinese factory early next year and continue with our global marketing and distribution plans," states Ron Wheet, CEO, Revolutions Medical Corporation.
The Company also launched its new interactive website to take advantage of new media technology with blogs, Twitter, and visual uploads, to keep shareholders, investors, and customers more current on news and events. Soon customers will be able to order syringes online in a safe, secure environment, and by the 3rd quarter 2011 will also be able to send images to access our proprietary MRI software tools; RevColor, RevDisplay, and Rev3d.
Revolutions Medical will host a reception at the Charleston Place Hotel, Charleston, SC on Thursday December 2nd from 6:30pm-9:30pm. Interested distributors and investors should RSVP to Sarah Kavalla by email address firstname.lastname@example.org
About Revolutions Medical Corporation
Revolutions Medical is a safety medical device and software application company. Its products include the RevVac Safety Syringe™ (FDA approved), safety blood drawing device, and the RevColorTM, RevDisplayTM and Rev3DTM proprietary software tools that are compatible with standard MRIs and standard Picture Archiving Computer Systems (PACS). The software suite's functionality includes color, 3D, and automatic segmentation and sorting of images.
For additional information, please visit Revolutions Medical corporate website: http://www.revolutionsmedical.com
Investor Resource Center
CEO Ron Wheet Audio Interview:
RevVac Safety Syringe Demonstration Video:
RevColor MRI Video:
To be added to the Revolutions Medical investor email list, please email with RMCP in the subject line.
Become a RevMed fan and follow the Company on Facebook -- visit http://www.Facebook.com/Revmed
The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The safe harbor for forward-looking statements contained in the Securities Litigation Reform Act of 1995 protects companies from liability for their forward-looking statements if they comply with the requirements of the Act.
CONTACT: Revolutions Medical Corporation Investor Relations: Scott Key (843) 518-0437 Skey@revolutionsmedical.com